Inventor · disambiguated record
Joseph J. Buggy
Also filed as: BUGGY JOSEPH · BUGGY JOSEPH J
51 granted patents·55 pending applications·962 citations·filing 2000–2024
99Inventor score
Top patents by PatentIndex Score
106 records- 0199US9181263B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2015·Granted Nov 10, 2015·40 cites·1 claims
- 0299US8883435B2Inhibitors of Bruton's tyrosine kinaseHONIGBERG LEE·Filed 2008·Granted Nov 11, 2014·77 cites·8 claims
- 0399US8883803B2Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumorsHONIGBERG LEE·Filed 2011·Granted Nov 11, 2014·77 cites·9 claims
- 0498US10751342B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2020·Granted Aug 25, 2020·5 cites·13 claims
- 0598US9139591B2Inhibitors of bruton's tyrosine kinaseHONIGBERG LEE·Filed 2012·Granted Sep 22, 2015·37 cites·20 claims
- 0698US9125889B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS INC·Filed 2014·Granted Sep 8, 2015·63 cites·2 claims
- 0798US9079908B2Inhibitors of Bruton'S tyrosine kinaseHONIGBERG LEE·Filed 2012·Granted Jul 14, 2015·38 cites·17 claims
- 0898US8999999B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS INC·Filed 2013·Granted Apr 7, 2015·66 cites·18 claims
- 0998US8940750B2Inhibitors of bruton's tyrosine kinaseHONIGBERG LEE·Filed 2012·Granted Jan 27, 2015·47 cites·10 claims
- 1098US8809273B2Inhibitors of Bruton's tyrosine kinaseHONIGBERG LEE·Filed 2011·Granted Aug 19, 2014·52 cites·8 claims
- 1197US10653696B2Use of inhibitors of bruton's tyrosine kinase (BTK)PHARMACYCLICS LLC·Filed 2019·Granted May 19, 2020·5 cites·9 claims
- 1297US9278100B2Inhibitors of bruton's tyrosine kinase for the treatment of solid tumorsHONIGBERG LEE·Filed 2011·Granted Mar 8, 2016·39 cites·2 claims
- 1397US9107924B2Inhibitors of Bruton'S tyrosine kinase for the treatment of solid tumorsPHARMACYCLICS INC·Filed 2013·Granted Aug 18, 2015·40 cites·3 claims
- 1497US8754090B2Use of inhibitors of bruton's tyrosine kinase (Btk)BUGGY JOSEPH J·Filed 2011·Granted Jun 17, 2014·70 cites·2 claims
- 1596US10016435B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2017·Granted Jul 10, 2018·12 cites·8 claims
- 1696US10004746B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2017·Granted Jun 26, 2018·9 cites·30 claims
- 1796US9814721B2Use of inhibitors of bruton'S tyrosine kinase (BTK)PHARMACYCLICS LLC·Filed 2016·Granted Nov 14, 2017·14 cites·11 claims
- 1896US9801883B2Use of inhibitors of bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2016·Granted Oct 31, 2017·11 cites·31 claims
- 1995US9801881B2Use of inhibitors of bruton's tyrosine kinase (BTK)PHARMACYCLICS LLC·Filed 2013·Granted Oct 31, 2017·13 cites·18 claims
- 2095US9556182B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Jan 31, 2017·11 cites·22 claims
- 2194US11672803B2Use of inhibitors of Brutons tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2020·Granted Jun 13, 2023·2 cites·24 claims
- 2294US10004745B2Use of inhibitors of Bruton'S tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2016·Granted Jun 26, 2018·7 cites·7 claims
- 2394US9415050B2Methods for the treatment of HER2 amplified cancerPHARMACYCLICS LLC·Filed 2014·Granted Aug 16, 2016·17 cites·21 claims
- 2494US7834054B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2009·Granted Nov 16, 2010·16 cites·6 claims
- 2593US8603521B2Formulations of histone deacetylase inhibitor and uses thereofLOURY DAVID J·Filed 2010·Granted Dec 10, 2013·11 cites·13 claims
- 2693US7420089B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2007·Granted Sep 2, 2008·17 cites·10 claims
- 2793US6875598B1Histone deacetylase-8 proteins, nuclei acids, and methods for useAPPLERA CORP·Filed 2000·Granted Apr 5, 2005·28 cites·7 claims
- 2892US7276612B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2004·Granted Oct 2, 2007·39 cites·18 claims
- 2991US9795605B2Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumorsPHARMACYCLICS LLC·Filed 2015·Granted Oct 24, 2017·6 cites·22 claims
- 3091US9717731B2TEC family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2013·Granted Aug 1, 2017·14 cites·6 claims
- 3191US8779171B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2013·Granted Jul 15, 2014·9 cites·15 claims
- 3290US8026371B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2010·Granted Sep 27, 2011·9 cites·12 claims
- 3389US10105552B2Formulations of histone deacetylase inhibitor and uses thereofPHARMACYCLICS LLC·Filed 2016·Granted Oct 23, 2018·2 cites·15 claims
- 3489US2023293532A1Use of inhibitors of brutons tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 3589US2023248730A1Use of inhibitors of brutons tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 3688US9403032B2Formulations of histone deacetylase inhibitor and uses therofPHARMACYCLICS LLC·Filed 2013·Granted Aug 2, 2016·3 cites·17 claims
- 3788US9128096B2Methods for determining cancer resistance to histone deacetylase inhibitorsBUGGY JOSEPH J·Filed 2010·Granted Sep 8, 2015·4 cites·8 claims
- 3888US8900565B2Indole derivatives as inhibitors of histone deacetylasePHARMACYCLICS INC·Filed 2012·Granted Dec 2, 2014·5 cites·2 claims
- 3988US8389570B2Hydroxamates as therapeutic agentsVERNER ERIK J·Filed 2011·Granted Mar 5, 2013·11 cites·15 claims
- 4087US7838234B2Methods for determining cancer resistance to histone deacetylase inhibitorsPHARMACYCLICS INC·Filed 2008·Granted Nov 23, 2010·3 cites·17 claims
- 4187US2025127781A1Use of inhibitors of bruton's tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 4285US7820711B2Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disordersPHARMACYCLICS INC·Filed 2007·Granted Oct 26, 2010·7 cites·27 claims
- 4384US8338416B2Indole derivatives as inhibitors of histone deacetylaseBUGGY JOSEPH J·Filed 2007·Granted Dec 25, 2012·3 cites·19 claims
- 4484US2022249494A1Use of inhibitors of brutons tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2022·Application pending·0 cites
- 4584US2022175785A1Use of inhibitors of brutons tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2022·Application pending·0 cites
- 4683US10016434B2Methods for the treatment of HER2 amplified cancerPHARMACYCLICS LLC·Filed 2017·Granted Jul 10, 2018·2 cites·14 claims
- 4783US2024065971A1Methods of treating abc-dlbcl using inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 4882US9724349B2Methods for the treatment of HER2 amplified cancerPHARMACYCLICS LLC·Filed 2016·Granted Aug 8, 2017·2 cites·11 claims
- 4982US8906954B2Selective inhibitors of histone deacetylasePHARMACYCLICS INC·Filed 2013·Granted Dec 9, 2014·4 cites·15 claims
- 5081US8466193B2Selective inhibitors of histone deacetylaseVERNER ERIK·Filed 2009·Granted Jun 18, 2013·6 cites·17 claims
Showing the top 50 of 106 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joseph J. Buggy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →